University of Minnesota
Minneapolis, Minnesota, 55455, United States
Location status: Recruiting
NCT Number: NCT06271707
The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.
Interested in participating?
Request Info18 year–85 year
All sexes
Interventional
Phase 4
Minneapolis, Minnesota, 55455, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
an ultrasound guided left stellate ganglion block with 5 mL of 0.5% bupivacaine
an ultrasound guided left stellate ganglion block with 5 mL of saline
Time frame: 168 hours after surgery
Incidence of Atrial fibrillation in the first 168 hours after surgery.
Time frame: 168 hours after surgery
Atrial fibrillation in first 24, 48, 72, 96, 120, and 144 hours; Other arrhythmias in first 24, 48, 72, 96, 120, 144 and 168 hours; Adverse events.
Contact information is provided by the study sponsor or research team.
University of Minnesota
Other
Left Sided Stellate Ganglion Blocks Impact on the Rate of Post-operative Atrial Fibrillation in Patients Undergoing Thoracic Surgery: A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07309991
Adenocarcinoma Of Esophagus, Digestive System Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT07605481
Continous Glucose Measurement, Digestive System Diseases
Seoul, Gangnam-gu Irwon-Ro 81, South Korea
View Trial DetailsNCT05950438
Esophagectomy
Chicago, Illinois, United States
View Trial DetailsNCT00260559
Digestive System Diseases, Digestive System Neoplasms
Pittsburgh, Pennsylvania, United States
View Trial Details